Analysts: more sales GlaxoSmithKline, high dividend yield

Over the current book year the total revenue will be 30,6 billion GBp (consensus estimates). This is slightly more than 2017's revenue of 30,19 billion GBp.

Historical revenues and results GlaxoSmithKline plus estimates 2018

The analysts expect for 2018 a net profit of 5,68 billion GBp. For this year the consensus of GlaxoSmithKline's result per share is a profit of 114 GBp. With this the price/earnings-ratio is 13,36.

Huge dividend GlaxoSmithKline

Per share the analysts expect a dividend of 80 GBp per share. Thus the dividend yield equals 5,25 percent. The average dividend yield of the pharmaceutical companies is a limited 0,5 percent.

Most recent target prices around 1618 GBp

The most recent recommendations for the pharmaceutical company are from UBS, Deutsche Bank and Bank of America Merrill Lynch.

GlaxoSmithKline's market value equals around 7476,13 billion . The GlaxoSmithKline stock was the past 12 months quite volatile. Since last February the stock is even 22 percent higher. This year the stock price moved between 1235 and 1649 GBp. Since 2008 the stock price is almost 21 percent higher.

At 18.35 the stock trades 2,88 percent higher at 1522,6 GBp.

Historical stock prices GlaxoSmithKline

ValueSpectrum.com News Wire & Equity Research: +31 084-0032-842
news@valuespectrum.com

Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.